These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3550321)

  • 1. [Use of a bioluminescence method for determining the number of viable BCG particles].
    Janaszek W; Aleksandrowicz J; Sitkiewicz D
    Med Dosw Mikrobiol; 1986; 38(4):215-21. PubMed ID: 3550321
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and validation of an ATP method for rapid estimation of viable units in lyophilised BCG Danish 1331 vaccine.
    Jensen SE; Hubrechts P; Klein BM; Hasløv KR
    Biologicals; 2008 Sep; 36(5):308-14. PubMed ID: 18614376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viability of freeze-dried Tice-substrain BCG by bioluminescent measurement of adenosine triphosphate.
    Shi MF; Klegerman ME; Groves MJ
    Microbios; 1989; 59(240-241):145-55. PubMed ID: 2687647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rapid assay of BCG vaccine viability by measuring the ATP content (author's transl)].
    Gheorghiu M; Lagranderie M
    Ann Microbiol (Paris); 1979; 130B(2):147-56. PubMed ID: 533067
    [No Abstract]   [Full Text] [Related]  

  • 5. Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine.
    Ho MM; Markey K; Rigsby P; Jensen SE; Gairola S; Seki M; Castello-Branco LR; López-Vidal Y; Knezevic I; Corbel MJ
    Vaccine; 2008 Aug; 26(36):4754-7. PubMed ID: 18586063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunochemical analysis of the hydrosoluble antigens of the BCG vaccine and alt-tuberculin].
    Kulagin PP; Martynova VA
    Probl Tuberk; 1967; 45(9):74-7. PubMed ID: 4975371
    [No Abstract]   [Full Text] [Related]  

  • 7. A simplified ATP method for the rapid control of cell viability in a freeze-dried BCG vaccine.
    Ugarova NN; Lomakina GY; Modestova Y; Chernikov SV; Vinokurova NV; Оtrashevskaya EV; Gorbachev VY
    J Microbiol Methods; 2016 Nov; 130():48-53. PubMed ID: 27585823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of viable units of BCG vaccine].
    Quiróz A; de Guerrero I
    Rev Ecuat Hig Med Trop; 1977; 30(3):273-6. PubMed ID: 384481
    [No Abstract]   [Full Text] [Related]  

  • 9. Size characterization of Mycobacterium bovis BCG (Bacillus Calmette Guérin) vaccine, Tice substrain.
    Zhang A; Groves MJ
    Pharm Res; 1988 Sep; 5(9):607-10. PubMed ID: 3073388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental research on utilization of bioluminescent technique to substitute the current viability count for BCG vaccine.
    Chen ZR; Cheng SG; An YQ; Cao XH
    Chin Med J (Engl); 1989 Dec; 102(12):906-10. PubMed ID: 2517734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of the living cell count of cariogenic microorganisms using the measurement of their ATP content in the bioluminescence procedure--a critical look at the method].
    Steinke A; Netuschil L; Riethe P
    Dtsch Zahnarztl Z; 1983 Oct; 38(10):918-20. PubMed ID: 6357751
    [No Abstract]   [Full Text] [Related]  

  • 12. [Application and examination of bioluminescent technique in the quality identification of BCG vaccines].
    An YQ
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Feb; 14(1):35-7, 63. PubMed ID: 1879009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity.
    Hiu IJ
    Nat New Biol; 1972 Aug; 238(86):241-2. PubMed ID: 4562114
    [No Abstract]   [Full Text] [Related]  

  • 14. Firefly luciferase assay of adenosine triphosphate as a tool of quantitation of the viability of BCG vaccines.
    Askgaard DS; Gottschau A; Knudsen K; Bennedsen J
    Biologicals; 1995 Mar; 23(1):55-60. PubMed ID: 7619437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of photometric and weight estimation of Mycobacterium content in homogenous BCG cultures containing Tween 80.
    Schuh V; Sír J; Galliová J; Svandová E
    Bull World Health Organ; 1966; 35(4):557-61. PubMed ID: 5335458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods of preparation and control of BCG vaccine].
    Romano M
    G Ital Mal Torace; 1969; ():Suppl 1:12-39. PubMed ID: 4893881
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of living Salmonella cells using bioluminescence.
    Urata M; Iwata R; Noda K; Murakami Y; Kuroda A
    Biotechnol Lett; 2009 May; 31(5):737-41. PubMed ID: 19169891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the morphology of the Czechoslovak and Danish BCG vaccine strain.
    Mohelská H; Prüchová J
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):328-33. PubMed ID: 4562612
    [No Abstract]   [Full Text] [Related]  

  • 19. [Purification and properties of acetokinases of BCG and M. phlei].
    Andrejew A; Orfanelli MT; Desbordes J
    Biochimie; 1975; 57(11-12):1389-90. PubMed ID: 177090
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of the firefly bioluminescent reaction for the rapid detection and counting of mycobacterium BCG.
    Janaszek W; Aleksandrowicz J; Sitkiewicz D
    J Biol Stand; 1987 Jan; 15(1):11-6. PubMed ID: 3104341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.